Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Final overall survival analysis of the phase 3 HERITAGE study demonstrates equivalence of trastuzumab-dkst to trastuzumab in HER2-positive metastatic breast cancer.
Breast Cancer Res Treat. 2021 Jul;188(2):369-377. doi: 10.1007/s10549-021-06197-5. Epub 2021 Jun 14.
Breast Cancer Res Treat. 2021.
PMID: 34125340
Free PMC article.
Clinical Trial.
Effect of a Proposed Trastuzumab Biosimilar Compared With Trastuzumab on Overall Response Rate in Patients With ERBB2 (HER2)-Positive Metastatic Breast Cancer: A Randomized Clinical Trial.
Rugo HS, Barve A, Waller CF, Hernandez-Bronchud M, Herson J, Yuan J, Sharma R, Baczkowski M, Kothekar M, Loganathan S, Manikhas A, Bondarenko I, Mukhametshina G, Nemsadze G, Parra JD, Abesamis-Tiambeng ML, Baramidze K, Akewanlop C, Vynnychenko I, Sriuranpong V, Mamillapalli G, Ray S, Yanez Ruiz EP, Pennella E; Heritage Study Investigators.
Rugo HS, et al. Among authors: mamillapalli g.
JAMA. 2017 Jan 3;317(1):37-47. doi: 10.1001/jama.2016.18305.
JAMA. 2017.
PMID: 27918780
Clinical Trial.
Item in Clipboard
Fixed dose combination of capecitabine and cyclophosphamide in metastatic breast cancer: Results from THE ENCLOSE phase 2/3 randomized multicenter study.
Gupta S, Biswas G, Babu S, Maksud TM, Lakshmaiah KC, Patel JG, Raja G, Boya RR, Patil P, Choudhury K, Bondarde SA, Neve RS, Bhat G, Mamillapalli G, Patel AA, Patel P, Joshi N, Bajaj V, Khan MA.
Gupta S, et al. Among authors: mamillapalli g.
Breast. 2021 Dec;60:147-154. doi: 10.1016/j.breast.2021.09.012. Epub 2021 Oct 1.
Breast. 2021.
PMID: 34624757
Free PMC article.
Clinical Trial.
Item in Clipboard
Efficacy, Safety, Pharmacokinetics, and Immunogenicity of DRL-Trastuzumab Versus Herceptin in Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: A Randomized Controlled Trial.
Reddy N, Reddy P, Ranpura A, Maharaj N, Arora R, Mamillapalli G, Adhav AS, Diwan AK, Manikhas A, Krasnozhon D.
Reddy N, et al. Among authors: mamillapalli g.
JCO Glob Oncol. 2024 Jan;10:e2200328. doi: 10.1200/GO.22.00328.
JCO Glob Oncol. 2024.
PMID: 38237093
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite